We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

66 hedge funds and large institutions have $132M invested in Enanta Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

51% more capital invested

Capital invested by funds: $87.3M → $132M (+$44.4M)

22% more funds holding

Funds holding: 54 → 66 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

41% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 22

Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
13
Reduced
22
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.5M
2
CCM
Consonance Capital Management
New York
+$6.83M
3
Millennium Management
Millennium Management
New York
+$2.61M
4
SM
Sabby Management
Florida
+$2.08M
5
EI
EAM Investors
California
+$1.64M

Top Sellers

Rank Fund Capital Flow
1
AP
AlpInvest Partners
Netherlands
-$9.18M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.43M
3
Franklin Resources
Franklin Resources
California
-$5.62M
4
SONJCPFA
State of New Jersey Common Pension Fund A
New Jersey
-$2.58M
5
SCM
Sigma Capital Management
Connecticut
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
76
Panagora Asset Management
Massachusetts
– -$310K -13,546 Closed
NSEDCP
77
NJ State Employees Deferred Compensation Plan
New Jersey
– -$287K -12,500 Closed
LOM
78
Loeb Offshore Management
New York
– -$209K -9,104 Closed
CCMH
79
Cornerstone Capital Management Holdings
New York
– -$119K -5,200 Closed
SCA
80
SAC Capital Advisors
Connecticut
– -$57K -2,500 Closed
BG
81
BlackRock Group
United Kingdom
– -$32K -1,382 Closed
1 2 3
4

ENTA Hedge Fund Activity: Q4 2013 in Review

66 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q4 2013, worth a combined $132M — up 51% from $87.3M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ENTA positions and 15 closed out — a net gain of 12 holders — while 13 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $31.5M. The largest seller was AlpInvest Partners, cutting an estimated $9.18M.

  • 66 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q4 2013, up from 54 in Q3 2013.
  • Funds reported $132M of Enanta Pharmaceuticals stock for Q4 2013, up 51% quarter-over-quarter.
  • 27 funds opened new Enanta Pharmaceuticals positions in Q4 2013 and 15 closed out, a net change of +12 holders.
  • The largest Enanta Pharmaceuticals buyer in Q4 2013 was Fidelity Investments, an estimated $31.5M added.
  • The largest Enanta Pharmaceuticals seller in Q4 2013 was AlpInvest Partners, an estimated $9.18M sold.

Based on aggregated 13F filings for Q4 2013.